Evaluation of Photon-Counting versus Energy-Integrating Detector CT for Obstructive CAD Detection
Overview
This multicentric study compared the diagnostic accuracy of dual-source photon-counting detector CT (PCD-CT) with energy-integrating detector CT (EID-CT) for detecting obstructive coronary artery disease (CAD) in symptomatic patients. Using invasive coronary angiography as the reference, PCD-CT demonstrated improved image quality and more accurate stenosis assessment, particularly in patients with calcifications.
Background
Coronary CT angiography (CCTA) is recommended as the first-line test for symptomatic patients with low to moderate likelihood of obstructive CAD. Traditional energy-integrating detector CT (EID-CT) systems face limitations such as lower spatial resolution and blooming artifacts, which can overestimate stenosis severity, especially in heavily calcified vessels. Photon-counting detector CT (PCD-CT) technology offers higher spatial resolution, spectral imaging capabilities, and reduced noise, potentially improving diagnostic accuracy. However, clinical data comparing first-generation dual-source PCD-CT to EID-CT in symptomatic patients remain limited.
Data Highlights
Parameter
PCD-CT Cohort
EID-CT Cohort
Number of Patients
143
109
Inclusion Criteria
≥18 years, ≥50% stenosis on CCTA, ICA within 2 months
Same as PCD-CT
Exclusion Criteria
Stent, CABG, poor image quality
Same as PCD-CT
Scan Parameters
120 or 140 kVp, UHR mode available (0.11 mm resolution)
Standard EID-CT protocols
Sites
Semmelweis University & Medical University of South Carolina
Semmelweis University Heart and Vascular Centre
Key Findings
PCD-CT provided superior image quality with higher spatial resolution and reduced blooming artifacts compared to EID-CT.
Diagnostic accuracy for detecting ≥50% and ≥70% coronary stenosis was improved using PCD-CT relative to EID-CT, validated against invasive coronary angiography.
Ultra-high resolution (UHR) mode in PCD-CT achieved in-plane resolution of 0.11 mm, enhancing visualization of coronary lumen and calcifications.
PCD-CT scans were performed using standardized protocols including beta-blockade and nitroglycerin to optimize image acquisition.
Patients with acute coronary syndromes and those with stents or bypass grafts were excluded to focus on stable symptomatic populations.
Clinical Implications
The improved spatial resolution and reduced artifacts of PCD-CT can enhance the accuracy of non-invasive coronary stenosis assessment, potentially reducing unnecessary invasive procedures. Adoption of PCD-CT technology may be particularly beneficial in patients with extensive coronary calcifications where EID-CT limitations are most pronounced. Clinicians should consider integrating PCD-CT into diagnostic pathways for symptomatic patients with intermediate CAD risk.
Conclusion
Dual-source PCD-CT demonstrates superior diagnostic performance over conventional EID-CT for detecting obstructive coronary artery disease in symptomatic patients. These findings support the clinical utility of PCD-CT as a more accurate and reliable imaging modality in coronary artery evaluation.
References
European and American guidelines on CAD assessment
DISCHARGE trial -- CCTA-based care pathways
Technical advantages of PCD-CT technology
Clinical evaluations of PCD-CT image quality and diagnostic accuracy
by Melinda Boussoussou, Milán Vecsey-Nagy, Zsófia Jokkel, Borbála Vattay, Anikó Kubovje, Barbara Sipos, Márton Kolossváry, Anikó Ilona Nagy, Lili Száraz, Sámuel Beke, Bernard Schmidt, Máté Kiss, Béla Merkely, Josua A. Decker, Tilman Emrich, Akos Varga-Szemes, Pál Maurovich-Horvat, Bálint Szilveszter
